HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$215.11
Day range
$212.75 - $219.54
Year range
$123.03 - $221.84
Market cap
6.24B USD
Avg Volume
294.84K
P/E ratio
53.72
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 97.80M | 16.65% |
Operating expense | 52.16M | 23.65% |
Net income | 79.36M | 192.00% |
Net profit margin | 81.15 | 150.31% |
Earnings per share | 2.66 | 106.11% |
EBITDA | 41.68M | 18.02% |
Effective tax rate | -65.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 731.07M | 24.26% |
Total assets | 1.24B | 26.24% |
Total liabilities | 102.22M | 5.96% |
Total equity | 1.14B | — |
Shares outstanding | 29.00M | — |
Price to book | 5.48 | — |
Return on assets | 8.70% | — |
Return on capital | 9.41% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 79.36M | 192.00% |
Cash from operations | 39.66M | -32.62% |
Cash from investing | -4.29M | 87.51% |
Cash from financing | 3.71M | 10.22% |
Net change in cash | 38.78M | 37.60% |
Free cash flow | 6.89M | -86.41% |
About
Founded
2015
Headquarters
Website
Employees
275
